David M. Smadja

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang, Paul Bastard, Zhiyong Liu et al. · Science · 2020 · 2.4K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients

David M. Smadja, Coralie L. Guérin, Richard Chocron et al. · Angiogenesis · 2020 · 265 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +15

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Circulating Endothelial Cells

David M. Smadja, Pascale Gaussem, Laëtitia Mauge et al. · Circulation · 2009 · 153 citations · Full text

Medicine, Cardiology, Clinical Sciences +17